Artrya Limited AYA.AX · Stock Open Artrya Limited in new tab
Analyst price targets
Recent rating changes, newest first
Artrya Limited Analysis (AYA.AX)
Is Artrya Limited a good investment? Artrya Limited (AYA.AX) is currently trading at 2.46 AUD. Market analysts have a consensus price target of 6.24 AUD. This suggests a potential upside from current levels.
Earnings Schedule: Artrya Limited is expected to release its next earnings report on March 2, 2027. The market consensus estimate for Forward EPS is -0.08.
Investor FAQ
Does Artrya Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is Artrya Limited?
Artrya Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be March 2, 2027. The company currently has a trailing EPS of -0.17.
Company Profile
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. It offers Salix, a suite of cloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. The company was incorporated in 2018 and is based in West Perth, Australia.
Community Discussion